Home/Filings/3/0001144204-11-011464
3//SEC Filing

CERTIFIED DIABETIC SERVICES INC 3

Accession 0001144204-11-011464

CIK 0001047153operating

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 3:51 PM ET

Size

24.4 KB

Accession

0001144204-11-011464

Insider Transaction Report

Form 3
Period: 2009-12-21
Holdings
  • Series 6 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2014-11-16Common Stock (5,500,000 underlying)
  • BD-1 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2010-09-17Common Stock (1,500,000 underlying)
  • Placement Agent Series A Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2013-11-29Common Stock (58,400 underlying)
  • Series C Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Common Stock (55,000,000 underlying)
  • Series D Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Common Stock (80,000,000 underlying)
  • Series 3 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.13Exp: 2011-02-05Common Stock (25,000,000 underlying)
  • Series 3 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.13Exp: 2011-06-26Common Stock (12,500,000 underlying)
  • Series 4 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2013-06-26Common Stock (12,500,000 underlying)
  • BD-2 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2012-09-17Common Stock (1,500,000 underlying)
  • BD Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Exp: 2010-09-17Common Stock (3,300,000 underlying)
  • Common Stock

    (indirect: By Vicis Capital Master Fund)
    3,571,900
  • Series E Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Common Stock (11,000,000 underlying)
  • Series 1 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2010-09-17Common Stock (25,000,000 underlying)
  • Series 2 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2012-09-17Common Stock (25,000,000 underlying)
  • Series 4 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2013-02-15Common Stock (25,000,000 underlying)
  • Series 5 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2012-11-16Common Stock (5,500,000 underlying)
Holdings
  • Series 3 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.13Exp: 2011-06-26Common Stock (12,500,000 underlying)
  • Series 5 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2012-11-16Common Stock (5,500,000 underlying)
  • BD Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Exp: 2010-09-17Common Stock (3,300,000 underlying)
  • BD-2 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2012-09-17Common Stock (1,500,000 underlying)
  • Series D Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Common Stock (80,000,000 underlying)
  • Series E Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Common Stock (11,000,000 underlying)
  • Series 4 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2013-02-15Common Stock (25,000,000 underlying)
  • Series 6 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2014-11-16Common Stock (5,500,000 underlying)
  • BD-1 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2010-09-17Common Stock (1,500,000 underlying)
  • Placement Agent Series A Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2013-11-29Common Stock (58,400 underlying)
  • Common Stock

    (indirect: By Vicis Capital Master Fund)
    3,571,900
  • Series C Convertible Preferred Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.05Common Stock (55,000,000 underlying)
  • Series 1 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2010-09-17Common Stock (25,000,000 underlying)
  • Series 2 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.07Exp: 2012-09-17Common Stock (25,000,000 underlying)
  • Series 3 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.13Exp: 2011-02-05Common Stock (25,000,000 underlying)
  • Series 4 Warrant to purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.15Exp: 2013-06-26Common Stock (12,500,000 underlying)
Footnotes (3)
  • [F1]Represents the indirect holdings of Vicis Capital LLC. All of the foregoing represents securities held directly by Vicis Capital Master Fund. Vicis Capital LLC acts as investment advisor to Vicis Capital Master Fund and therefore has voting and dispositive power over all the foregoing shares. For the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Vicis Capital LLC may be deemed to be the beneficial owner of, but hereby disclaims such beneficial ownership of, the foregoing shares.
  • [F2]Immediately.
  • [F3]None.

Documents

1 file

Issuer

CERTIFIED DIABETIC SERVICES INC

CIK 0001047153

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001047153

Filing Metadata

Form type
3
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 3:51 PM ET
Size
24.4 KB